J Nephropathol. 2012;1(3): 123-125. doi: 10.5812/nephropathol.8106
PMID: 24475401        PMCID: PMC3886149

Editorial

Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients


Cited by CrossRef: 8


1- Baradaran A. Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. DARU. 2013;21(1):19 [Crossref]
2- Nasri H. Reply: Oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats. Ann Saudi Med. 2013;33(5):510 [Crossref]
3- Nasri H. The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. Hum Exp Toxicol. 2014;33(10):1085 [Crossref]
4- Nematbakhsh M, Nasri H. Cisplatin nephrotoxicity may be sex related. Kidney International. 2013;83(6):1201 [Crossref]
5- Nasri H. C-Phycocyanin attenuates cisplatin-induced nephrotoxicity in mice. Renal Failure. 2013;35(7):1054 [Crossref]
6- Nasri H. Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients. Jundishapur J Microbiol. 2014;7(2) [Crossref]
7- Nasri R. Renoprotective effects of metformin. DARU. 2013;21(1):36 [Crossref]
8- Nasri H. Re Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism. 2013;39(4):375 [Crossref]